Several genotypes have been shown to moderate the impact of cannabis use on psychosis risk, particularly those involved in the dopamine function, such as AKT1. Finally, the results indicate that cannabis use is associated with an earlier onset of psychosis and increased risk of transition in individuals at CHR of psychosis. This evidence concerns the gene AKT1 and psychotic disorder.